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ABSTRACT: CDKL5 deficiency disorder (CDD) is a severe neurodevelopmental disease caused by mutations in 
the X-linked CDKL5 gene. Children affected by CDD display a clinical phenotype characterized by early-onset 
epilepsy, intellectual disability, motor impairment, and autistic-like features. Although the clinical aspects 
associated with CDKL5 mutations are well described in children, adults with CDD are still under-characterized. 
Similarly, most animal research has been carried out on young adult Cdkl5 knockout (KO) mice only. Since age 
represents a risk factor for the worsening of symptoms in many neurodevelopmental disorders, understanding age 
differences in the development of behavioral deficits is crucial in order to optimize the impact of therapeutic 
interventions. Here, we compared young adult Cdkl5 KO mice with middle-aged Cdkl5 KO mice, at a behavioral, 
neuroanatomical, and molecular level. We found an age-dependent decline in motor, cognitive, and social 
behaviors in Cdkl5 KO mice, as well as in breathing and sleep patterns. The behavioral decline in older Cdkl5 KO 
mice was not associated with a worsening of neuroanatomical alterations, such as decreased dendritic arborization 
or spine density, but was paralleled by decreased neuronal survival in different brain regions such as the 
hippocampus, cortex, and basal ganglia. Interestingly, we found increased β-galactosidase activity and DNA repair 
protein levels, γH2AX and XRCC5, in the brains of older Cdkl5 KO mice, which suggests that an absence of Cdkl5 
accelerates neuronal senescence/death by triggering irreparable DNA damage. In summary, this work provides 
evidence that CDKL5 may play a fundamental role in neuronal survival during brain aging and suggests a possible 
worsening with age of the clinical picture in CDD patients. 
 




CDKL5 deficiency disorder (CDD, OMIM #300203) is a 
rare X-linked neurodevelopmental disorder caused by 
mutations in the cyclin-dependent kinase-like 5 gene 
(CDKL5). Although the clinical manifestations of 
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individuals with the CDKL5 mutation closely resemble 
some features of Rett syndrome (RTT) [1], including hand 
stereotypies, autistic-like features, scarce acquisition of 
language and conscious hand use, it has now become clear 
that CDD represents an independent clinical entity with 
unique characteristics [2, 3]. The clinical features 
commonly associated with CDKL5 mutations include 
early-onset seizures, cortical visual impairment, 
intellectual disability, and gross motor impairment [4-8]. 
Even if the clinical aspects associated with CDKL5 
mutations are well described in children, adults with CDD 
are still under-characterized.  
CDKL5 is highly expressed in the brain, in particular 
in the forebrain regions such as the cerebral cortex and the 
hippocampus; the expression of this gene is mainly 
neuronal, suggesting its potential importance in brain 
function. To delineate how CDKL5 deficiency leads to 
impaired brain function, several cellular and animal 
models of the disease have been created [9-12]. Mouse 
models of CDD (Cdkl5 knockout (KO) mice) recapitulate 
multiple clinical symptoms of the disorder, such as motor 
dysfunction, cognitive deficits, visual impairment, and 
altered anxiety-related behaviors. Studies of brain 
development and function in CDD mouse models have 
demonstrated that CDKL5 plays a key role in neuronal 
morphogenesis, dendritic arborization of hippocampal 
and cortical principal neurons, and in synaptic 
connectivity [9, 13-18]. CDKL5 deficiency reduces spine 
maturation, a defect that is consistent with a reduced 
expression of the AMPA-R GluA2 subunit [16, 19, 20]. 
In addition, long-term plasticity of excitatory synapses is 
impaired in cortical slices of Cdkl5 KO mice, and 
excitatory synaptic transmission is reduced in mouse 
hippocampal cultures silenced for Cdkl5 [21]. This 
evidence strongly suggests that CDKL5 plays a central 
role in neuronal morphogenesis and excitatory synaptic 
transmission and implies that defective neuronal circuit 
function underlies CDD. 
Recent evidence has highlighted the role of CDKL5 
in neuronal survival [14, 22, 23]. It has been demonstrated 
that in the postnatal developing mouse hippocampus, loss 
of Cdkl5 increases the proliferation rate of neuronal 
precursors but causes the death of immature newborn 
neurons, thereby modulating the intricate balance 
between precursor proliferation and survival. 
Interestingly, CDKL5 deficiency increases the 
vulnerability of neural cells to different neurotoxic/ 
excitotoxic stimuli, suggesting that CDKL5 mutations 
have an endangering action that is likely to sensitize 
neurons in the brain to neurotoxic conditions known to 
promote neuronal death.  
Although age is a risk factor for the worsening of 
symptoms in many neurodevelopmental disorders, such 
as Down syndrome [24], Fragile X syndrome [25, 26], and 
autism spectrum disorders [27, 28], the age-related 
phenotype in CDD has not yet been investigated. In the 
current study, we address the question of whether there 
are changes to the behavioral and neuroanatomical 
phenotypes in CDD as a function of age, using a well-
characterized mouse model of CDD, the Cdkl5 KO mouse 
[9].  
 




The mice used in this work derive from the Cdkl5 KO 
strain in the C57BL/6N background developed in [9] and 
backcrossed in C57BL/6J for three generations. Cdkl5 KO 
mice (-/Y) and age matched controls (wild-type; +/Y), 
when possible littermates, were used for all experiments 
and genotyped as previously described [9]. Mice were 
housed three to five animals per cage and maintained on a 
12 h light: 12 h dark cycle in a temperature- (23°C) and 
humidity-controlled environment with standard mouse 
chow and water ad libitum. The animals’ health and 
comfort were controlled by the veterinary service. All 
research and animal care procedures were performed 
according to protocols approved by the Italian and 
European Community law for the use of experimental 
animals and by Bologna University Bioethical 
Committee. In this study, all efforts were made to 
minimize animal suffering and to keep the number of 
animals used to a minimum. A total of 147 animals were 
used for behavioral, neuroanatomical, and molecular 
studies. The number of mice included in individual 




The sequence of the tests was arranged to minimize the 
effect of one test influencing subsequent evaluation of the 
next test, and mice were allowed to recover for several 
days between different tests. All behavioral studies and 
analyses were performed blind to genotype. Mice were 
allowed to habituate to the testing room for at least 1 h 
before the test, and testing was always performed at the 
same time of the day. 
 Marble Burying - The marble burying test was 
performed by placing animals individually in a cage 
(dimensions 45 x 23 cm) with 5 cm of unscented standard 
bedding material. Before testing, animals were allowed to 
habituate to the novel environment for 5 min. After mice 
were gently removed from the cage and twenty marbles 
(15 mm in diameter) were spaced out equally on the top 
of the bedding in a matrix of five rows per four columns. 
Animals were allowed to explore the cage with marbles 
undisturbed for 30 min and at the end of the test, animals 
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were gently removed from the cage to avoid disturbing the 
bedding. The number of marbles that were at least two-
thirds buried were counted. 
 
 
Table1. Body weight (mean  SD) in grams of wild type (Cdkl5 +/Y) and knockout (Cdkl5 
-/Y) male mice at different ages. 
 
Months Cdkl5 +/Y Cdkl5 -/Y p 
1 14.82 ± 0.71 (n = 12) 14.94 ± 0.36 (n = 12) n.s. 
2 21.29 ± 0,49* (n = 12) 21.02 ± 0.41* (n = 12) n.s. 
3-4 25.53 ± 0.55** (n = 12) 25.41 ± 0.37** (n = 12) n.s. 
6-7 27.76 ± 0.77*** (n = 12) 28.60 ± 0.59*** (n = 12) n.s. 
12-14 31.81 ± 0.53**** (n = 12) 33.04 ± 0.62**** (n = 12) n.s. 
 
 
* Significantly different from 1 month; ** significantly different from 2 months; *** significantly different from 
3-4 months; **** significantly different from 6-7 months. n.s. not statistically significant. Difference considered 
significant when p < 0.05 (Duncan’s test after ANOVA). 
Hind-limb Clasping - Animals were suspended by 
their tail for 2 min and hind-limb clasping was assessed 
independently by two operators from video recordings. A 
clasping event is defined as the retraction of limbs into the 
body and toward the midline. The time spent hind-limb 
clasping was expressed as a percentage.  
Accelerating Rotarod Assay. - Before the first test 
session, animals were briefly (30 s) trained at a constant 
speed of 5 rpm on the rotarod apparatus (Ugo Basile). 
Testing was performed at an accelerating linear speed (5–
35 rpm within 270 s + 30 s max speed). Four testing trials 
with an intertrial interval of 1 h were performed. The 
number of passive rotations (rotation in which the mouse 
does not perform any coordinated movement but is 
passively transported by the rotating apparatus) were 
recorded for each trial. The mean frequency of passive 
rotations in the four testing trials was calculated and 
expressed as fold of the wild-type counterpart of the same 
age. 
Morris Water Maze - Mice were trained to locate a 
hidden escape platform in a circular pool. The apparatus 
consisted of a circular water tank (1 m in diameter, 50 cm 
high) with a transparent round escape platform (10 cm2) 
placed in a fixed position. The tank was filled with tap 
water at a temperature of 22°C up to 0.5 cm above the top 
of the platform, and the water was made opaque with 
milk. In the experimental room, intra-maze and extra-
maze visual cues were placed to enable spatial orientation. 
Mouse behavior was automatically video-tracked 
(EthoVision 3.1; Noldus Information Technology B.V.). 
During training, each mouse was subjected to either 1 
swimming session of 4 trials (day 1) or 2 sessions of 4 
trials per day (days 2–5), with an intersession interval of 
1 h (acquisition phase). Mice were allowed to search for 
the platform for up to 60 s. If a mouse did not find the 
platform, it was gently guided to it and allowed to remain 
there for 15 s. During the intertrial interval (15 s), mice 
were placed in an empty cage. The latency to find the 
hidden platform was used as a measure of learning. 
Twenty-four h after the last acquisition trial, on day 6, the 
platform was removed, and a probe test was run. Animals 
were allowed to search for the platform for up to 60 s. The 
latency of the first entrance into the former platform area, 
the frequency of entrances, and the maximum velocity 
were analyzed. All experimental sessions were carried out 
between 9.00 am and 3.00 pm. A visual cue test was 
conducted 30 min after the probe test to assess motivation 
and visual ability.  
Assessment of visual responses - The methods 
employed in [8] were used. The animals were box-
anesthetized and maintained with isoflurane (respectively, 
3% and 1%), placed on a stereotaxic frame, and the head 
fixed in place using ear bars. Body temperature was 
controlled using a heating pad and a rectal probe to 
maintain the animal’s body at 37°C. Local anesthesia was 
provided using subcutaneous lidocaine (2%) injection and 
eyes were protected with dexamethasone-based ointment 
(Tobradex, Alcon Novartis). The scalp was removed, and 
the skull carefully cleaned with saline. The skin was 
secured to the skull using cyanoacrylate. Then a thin layer 
of cyanoacrylate was poured over the exposed skull to 
attach a custom-made metal ring (9 mm internal diameter) 
centered over the binocular visual cortex. When the glue 
dried, a drop of transparent nail polish was spread over the 
area to ameliorate optical access. After surgery, the 
animals were placed in a heated box and monitored to 
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ensure the absence of any sign of discomfort. Before any 
other experimental procedure, mice were left to recover 
for at least 36 h. During this period, paracetamol (5 
mg/ml) was administered in the water as an analgesic 
therapy. Non-invasive transcranial intrinsic optical signal 
(IOS) recordings were performed under isoflurane 
anesthesia (0.5–1%) supplemented with an intraperitoneal 
injection of chlorprothixene hydrochloride (1.25 mg/kg). 
Images were obtained using an Olympus microscope 
(BX50WI). Red light illumination was provided by 8 red 
LEDs (625 nm, Knight Lites KSB1385–1P) attached to 
the objective (Zeiss Plan-NEOFLUAR 5x, NA: 0.16) 
using a custom-made metal LED holder. The animal was 
secured under the objective using a ring-shaped 
neodynium magnet mounted on an arduino-based 3D 
printed imaging chamber that also controls eye shutters 
and a thermostated heating pad [8]. Visual stimuli were 
generated using Matlab Psychtoolbox and presented on a 
gamma-corrected 9.7-inch monitor, placed 10 cm away 
from the eyes of the mouse. Contrast reversing Gabor 
patches (temporal frequency: 4 Hz, duration: 1 s) were 
presented in the binocular portion of the visual field (−10° 
to +10° relative to the horizontal midline and −5° to +50° 
relative to the vertical midline) with a spatial frequency of 
0.03 cycles per degree, mean luminance 20 cd/m2, and a 
contrast of 90%. Visual stimulation was time locked with 
a 16 bit depth acquisition camera (Hamamatsu digital 
camera C11440) using a parallel port trigger. 
Interstimulus time was 14 s. Frames were acquired at 30 
fps with a resolution of 512 × 512 pixels, low-pass filtered 
with a 2D average spatial filter (30 pixels, 117 μm2 square 
kernel), and down-sampled to 128 × 128 pixels. The 
signal was averaged for at least 120 trials and down-
sampled to 10 fps. Fluctuations of reflectance (R) for each 
pixel were computed as the normalized difference from 
the average baseline (ΔR/R). For each recording, an image 
representing the mean evoked response was computed by 
averaging frames between 0.5 and 2.5 s after stimulation. 
A region of interest (ROI) was automatically calculated 
on the mean image of the response, by selecting pixels in 
the lowest 30% ΔR/R of the range between the maximal 
and minimal intensity value. Mean evoked responses were 
quantitatively measured as the average intensity inside the 
ROI. To weaken background fluctuations a manually 
selected polygonal region of reference (ROR) was 
subtracted. The ROR was placed where no stimulus 
response, blood vessel artifact, or irregularities of the 
skull were observed. 
Fear conditioning test - The fear conditioning test 
was performed as described in [11]. The test occurred in 
a 30 x 24 x 21 cm sound-isolated operant chamber (Ugo 
Basile) in the presence of light (90 lux). Mice were trained 
and tested on 2 consecutive days. Training consisted of 
placing a mouse in the chamber and allowing it to explore 
freely for 2 min, after which a loud tone (85 dB, 2 kHz) 
was played for 20 s. A 0.75-mA foot shock was 
administered for the final two seconds of the loud tone. A 
second pairing of sound cue and shock was repeated after 
1 min. The mouse was removed from the chamber 90 sec 
after the second shock. The animal was returned to the 
same chambers without a tone or shock, twenty-four hours 
after training, to test for context-dependent learning. At 
the end of 5 min in the contextual test, the mouse was 
returned to the home cage. One hour later, the mouse was 
placed in a novel chamber and allowed to explore freely 
for 2 min, after which a cue tone (85 dB, 2 kHz) was 
played for 1 min. Freezing behavior, defined as no 
movement except for respiration, was recorded using 
EthoVision 14XT software (Noldus Information 
Technology B.V.). The freezing behavior was measured 
when the animal returned to the testing chamber 
(contextual) and upon hearing the testing tone (cue) in the 
novel chamber. 
Non-invasive assessment of sleep and breathing 
pattern - Hypnic and respiratory phenotypes of mice were 
assessed non-invasively with a validated technique based 
on whole-body plethysmography (WBP) as previously 
described [29, 30]. Mice were individually placed inside 
a modified 2-chamber WBP (PLY4223, Buxco, 
Wilmington), with the internal volume of the mouse 
chamber reduced to 0.97 L. Recordings of respiratory 
activity were performed for 8 hours during the light 
period. The wake-sleep states of mice were discriminated 
based on visual inspection of the WBP signal, using a 
validated procedure [29, 30]. This allowed the 
simultaneous evaluation of hypnic and respiratory 
phenotype, including the quantification of augmented 
breaths (sighs) and sleep apneas. Apneas and sighs were 
detected as breaths with duration (apneas) or tidal volume 
(sighs) greater than three times the average breath 
duration or tidal volume, respectively, for each mouse and 
sleep state. Because sighs often precede apneas, we 
further categorized apneas as post-sigh apneas if they 
followed a sigh by ≤8 s [31]. 
 
Histological and Immunohistochemistry Procedures 
 
For histological and immunohistochemistry analysis 
some animals from each experimental group were 
euthanized with isoflurane (2% in pure oxygen) and 
sacrificed through cervical dislocation. Brains were 
quickly removed and cut along the midline. Left 
hemispheres were processed for Golgi staining or 
ƴH2AX-immunolabeling, while right hemispheres were 
used for β-galactosidase staining or immunofluorescence 
as described below. All steps of sectioning, imaging, and 
data analysis were conducted blindly.  
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Golgi staining - Golgi staining was performed using 
the FD Rapid Golgi Stain TM Kit (FD 
NeuroTechnologies) according to the manufacturer’s 
instructions. Briefly, left hemispheres were immersed in 
the impregnation solution containing mercuric chloride, 
potassium dichromate, and potassium chromate, and 
stored at room temperature in darkness for 2-3 weeks. 
Hemispheres were cut with a microtome into 100-µm-
thick coronal sections that were directly mounted onto 
gelatin-coated slides and were air dried at room 
temperature in the dark for an additional 2-3 days. After 
drying, sections were rinsed with distilled water and 
subsequently stained in the developing solution of the kit. 
A light microscope (Leica Mycrosystems) equipped with 
a motorized stage and focus control system and a color 
digital camera (Coolsnap-Pro; Media Cybernetics) were 
used for neuronal tracing and to take bright field images. 
Measurements were carried out using Image Pro Plus 
software (Media Cybernetics).  
Neuronal tracing - Dendritic trees of Golgi-stained 
granule cells of the hippocampal dentate gyrus (DG) and 
pyramidal cells (basal dendrites) from layers II/III of the 
primary visual cortex (V1), were traced with a dedicated 
software that was custom-designed for dendritic 
reconstruction (Immagini Computer), interfaced with 
Image Pro Plus (Media Cybernetics). The dendritic tree 
(10-12 per animal) was traced live, at a final 
magnification of 500X, by focusing into the depth of the 
section. The operator starts tracing the branches that 
emerge from the cell soma and, after having drawn the 
first parent branch goes on with all the daughter branches 
of the next order in a centrifugal direction [32]. At the end 
of tracing, the program reconstructs the total dendritic 
length and the total number of branches.  
Spine density and morphology - In Golgi-stained 
sections, spines of pyramidal neuron of CA1 and of layer 
II-III of V1 were acquired using a 100X oil immersion 
objective lens. Dendritic spine density was measured by 
manually counting the number of dendritic spines on 
apical dendrites of CA1 and V1 pyramidal neurons. In 
each mouse, 12-15 dendritic segments (segment length: 
10 µm) from each zone were analyzed and spine density 
was expressed as total number of spines per 10 µm. Based 
on their morphology, dendritic spines can be divided into 
two different categories that reflect their state of 
maturation: immature spines (filopodia, thin and stubby-
shaped) and mature spines (mushroom- and cup-shaped). 
The number of spines belonging to each class was counted 
and expressed as a percentage. 
ƴH2AX-immunolabeling - Hemispheres were fixed 
by immersion in Glyo-Fixx (Thermo Electron Corp) for 
24 h and embedded in paraffin. The forebrain was 
coronally sectioned into 8-μm-thick sections that were 
attached to poly-lysine-coated slides. One out of 12 
sections from the hippocampal formation was stained 
using a rabbit polyclonal anti-phospho-ƴH2AX-Ser139 
(1:1000; Abcam) antibody. Sections were retrieved with 
citrate buffer (pH 6.0) at 98°C for 40 min before 
incubation with the antibody and were processed as 
previously described [33]. Sections were incubated with a 
Cy3-conjugated anti-rabbit (1:200; Jackson 
Immunoresearch) secondary antibody and nuclei were 
counterstained with Hoechst 33342 (Sigma-Aldrich). 
Fluorescent images were taken using a Nikon Eclipse 
E600 microscope equipped with a Nikon Digital Camera 
DXM1200 (ATI system) under constant microscope 
settings. The intensity of Cy3 staining corresponding to 
the ƴH2AX signal was quantified in CA1 and CA3 layers 
and expressed as Optical Intensity/Area. 
β-galactosidase staining - For β-galactosidase 
staining hemispheres were fixed by immersion in 4% PFA 
in 100 mM PBS, pH 7.4, stored in fixative for 48 h, kept 
in 20% sucrose for additional 24 h, and then frozen with 
dry ice. Hemispheres were cut with a freezing microtome 
into 30-μm-thick coronal sections that were serially 
collected. One out of 6 free-floating sections from the 
hippocampal formation and the primary somatosensory 
cortex (S1) were washed and incubated for 24 h with 1 
mg/ml X-gal (Sigma-Aldrich) in the staining buffer 
supplemented with 5 mM potassium ferricyanide (Sigma-
Aldrich) and 5 mM potassium ferrocyanide (Sigma-
Aldrich) at 37°C. Stained samples were washed with PBS 
three times, dehydrated in ethanol of ascending purity (50, 
70, 80, 90, and 100%, 2 min each) and mounted on 
gelatin-coated slides. Bright field images were taken 
under constant settings with a light microscope (Leica 
Mycrosystems) equipped with a motorized stage and 
focus control system and a color digital camera 
(Coolsnap-Pro; Media Cybernetics) and intensity of blue 
staining corresponding to the β-galactosidase signal was 
quantified in CA1, CA3, and from layers II/III to layer V 
of the S1, and expressed as Optical Intensity/Area. 
Immunofluorescence – For immunofluorescence 
(i.e., cleaved caspase-3, NeuN, GFAP, S100 and TH) 
analyses hemispheres were fixed and cut in 30-μm-thick 
coronal sections as described above.  
NeuN staining - For NeuN immunofluorescence, one 
out of every 6 sections from the hippocampal formation 
were incubated overnight with a mouse monoclonal anti-
NeuN antibody (1:250; Millipore). The following day the 
sections were washed and incubated with a Cy3-
conjugated anti-mouse IgG secondary antibody (1:200; 
Jackson Immunoresearch) and nuclei were counterstained 
with Hoechst 33342 (Sigma-Aldrich). Fluorescent images 
were acquired using a Nikon Eclipse TE600 microscope 
equipped with a Nikon Digital Camera DXM1200 ATI 
System (Nikon Instruments Inc.). The number of Hoechst 
positive nuclei in CA1 were manually counted using the 
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point tool in Image Pro Plus (Media Cybernetics) and cell 
density was established as Hoechst positive cells/mm3. 
The density of neuron (NeuN) and pyknotic cells was 
established as cells/mm3.  
Cleaved caspase-3 staining - For cleaved caspase-3 
immunofluorescence, one out of 6 sections from the 
hippocampal formation and V1 were incubated overnight 
with a rabbit polyclonal anti-cleaved caspase-3 antibody 
(1:200; Cell Signaling Technology). The following day 
the sections were washed and incubated with an HRP-
conjugated anti-rabbit secondary antibody (1:200; 
Jackson Immunoresearch). Detection was performed 
using the TSA Cyanine 3 Plus Evaluation Kit (Perkin 
Elmer) and nuclei were counterstained with Hoechst 
33342 (Sigma-Aldrich). Fluorescent images were 
acquired using a Nikon Eclipse TE600 microscope 
equipped with a Nikon Digital Camera DXM1200 ATI 
System (Nikon Instruments Inc.). The density of apoptotic 
(cleaved caspase-3 positive) was established as 
cells/mm3.  
GFAP-staining - Immunostaining for glial fibrillary 
acidic protein (GFAP) was performed on one out of 6 
sections from the hippocampal formation using a mouse 
monoclonal anti-GFAP (1:400; Sigma-Aldrich) primary 
antibody, and a Cy3-conjugated anti-mouse IgG (1:200; 
Jackson Immunoresearch) secondary fluorescent 
antibody. Nuclei were counterstained with Hoechst 33342 
(Sigma-Aldrich) and fluorescent images were acquired as 
above described. The number of GFAP-positive cells in 
the molecular layer of the hippocampal DG were 
manually counted and cell density was established as 
GFAP positive cells/mm3.  
S100-staining - Immunostaining for S100 protein 
was performed on one out of every 6 sections from the V1 
cortex formation using a mouse monoclonal anti-S100 
(1:200; Abcam) primary antibody, and a Cy3-conjugated 
anti-rabbit IgG (1:200; Jackson Immunoresearch) 
secondary fluorescent antibody. Nuclei were 
counterstained with Hoechst 33342 (Sigma-Aldrich) and 
fluorescent images were acquired as described above. The 
number of S100-positive cells in the layers II/III of the 
V1 cortex were manually counted and cell density was 
established as S100 positive cells/mm3. 
TH-staining - For tyrosine hydroxylase (TH) 
immunostaining one out of 4 coronal sections 
representing the medial and caudal striatum were stained 
using a rabbit polyclonal anti-TH (1:200; Boster 
Biological Technology) primary antibody, and an anti-
rabbit IgG (1:200; Jackson Immunoresearch) secondary 
fluorescent antibody. Nuclei were counterstained with 
Hoechst 33342 (Sigma-Aldrich) and fluorescent images 
were acquired using a Nikon Eclipse TE600 microscope 
equipped with a Nikon Digital Camera DXM1200 ATI 
System (Nikon Instruments Inc.). The total number of TH 
positive neurons in the substantia nigra (SN) and ventral 
tegmental area (VTA) was estimated by multiplying the 
number counted in the series of sampled sections by the 
inverse of the section sampling fraction (section sampling 
fraction = 1/4).  
c-Fos, VGluT1 and Homer1bc immunofluorescence 
- Immunofluorescence analyses were conducted as in 
[18]. Animals were anesthetized with an intraperitoneal 
injection of Zoletil/Xylazine (Sigma-Aldrich) and 
transcardially perfused with ice-cold PFA (4% in 100 mM 
PBS, pH 7.4). Brains were dissected out and kept in the 
same fixative solution overnight at 4 °C. The brains were 
then placed in cryoprotection solutions (10, 20, and 30% 
sucrose-PBS solutions), cut in coronal 30-μm-thick 
sections with a cryostat and stored at −20 °C in a solution 
containing 30% ethylene glycol and 25% glycerol until 
use. For immunofluorescence processing, cryosections 
were rinsed in PBS, placed in a solution containing 0.05% 
Triton X-100 and 10% normal donkey serum (NDS) in 
PBS for 1 h, followed by overnight incubation at room 
temperature with the following primary antibodies: rabbit 
polyclonal anti-cFos (1:500; Cell Signaling), rabbit 
polyclonal anti-Homer1bc (1:500; Synaptic System), 
rabbit polyclonal anti-VGluT1 (1:5000; Millipore). The 
following day, the sections were rinsed and incubated 
with suitable fluorescent secondary antibodies (1:1000; 
Jackson Immunoresearch). After several PBS washes, the 
sections were mounted on gelatin-coated glass slides and 
cover slipped with Dako fluorescence mounting medium 
(Dako Italia). For c-Fos cells density analyses, 8 serial 
optical sections were captured with a laser scanning 
confocal microscope (LSM5 Pascal; Zeiss) with a 40X 
objective (1.0 NA) using a 1-μm Z-step. Confocal images 
were acquired in the pyramidal layer of CA1 whereas 
micrographs spanning from the pial surface to the white 
matter were captured in S1 and V1 cortical areas as in 
[17]. Acquisition settings were kept constant throughout 
all imaging sessions, cells were manually counted on 
merged z-stacks using the point tool in ImageJ and their 
density was expressed as cells/mm2. Homer1bc puncta in 
the neuropil were analyzed on five serial optical sections 
(0.5 μm Z-step size) that were acquired from layers II/III 
and V of the S1 and V1 cortices with a confocal 
microscope (LSM5 Pascal; Zeiss) using a 100X objective 
(1.4 NA) and the pinhole set at 1 Airy unit. Synaptic 
puncta were manually counted using the point tool in 
ImageJ, included in the dataset if present in at least two 
consecutive optical sections. Homer1bc puncta are 
expressed as density (puncta/100 µm2). For the 
Homer1bc-VGluT1 co-apposition analysis, synaptic 
puncta in the neuropil from layers II/III and V of the S1 
and V1 cortices were captured by using a laser scanning 
confocal microscope (LSM900; Zeiss) with a 63X 
objective (1.4 NA) and the pinhole set at 1 Airy unit on 
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five serial optical sections (0.5 μm Z-step size). Co-
appositions between postsynaptic Homer1bc and 
presynaptic VGluT1 signals were assessed by visual 
inspection in the three orthogonal planes and puncta were 
considered as co-apposed (i.e: putative synaptic contacts) 
when no black pixels were detected between signals. 
Synaptic puncta were manually counted and included in 
the dataset if present in at least two consecutive optical 
sections. The quantitation of Homer1bc-VGluT1 co-
apposition is presented as percentage of VGluT1 puncta 
juxtaposed to Homer1bc.  
 
   
 
 
Figure 1. Age-dependent deterioration of behavior in Cdkl5 KO mice. (A) Marble burying test in young adult Cdkl5 -/Y (n = 38) 
and Cdkl5 +/Y (n = 31) mice, and middle-aged Cdkl5 -/Y (n = 29) and Cdkl5 +/Y (n = 22) mice. (B) Fear conditioning paradigm, 
measuring time spent freezing in response to a mild footshock, upon the return to the testing chamber (context) and upon hearing the 
testing tone (cue) in adult Cdkl5 -/Y (n = 29) and Cdkl5 +/Y (n = 28) mice, and middle-aged Cdkl5 -/Y (n = 22) and Cdkl5 +/Y (n = 20) 
mice. (C) Frequency of passive rotations (rotations in which the mouse does not perform any coordinated movement but is passively 
transported on the rotating apparatus) in adult Cdkl5 -/Y (n = 30) and Cdkl5 +/Y (n = 19) mice, and middle-aged Cdkl5 -/Y (n = 13) and 
Cdkl5 +/Y (n = 10) mice. The mean frequency of passive rotations was expressed as fold of the wild-type counterparts of the same age. 
(D) Percentage of time spent hind-limb clasping during a 2-min interval in adult Cdkl5 -/Y (n = 29) and Cdkl5 +/Y (n =19) mice, and 
middle-aged Cdkl5 -/Y (n = 27) and Cdkl5 +/Y (n = 19) mice. Values represent mean ± SEM. *p< 0.05, **p< 0.01, ***p< 0.001 (Dunn’s 
test after Kruskal-Wallis). 
Western Blotting 
 
Animals were euthanized with isoflurane (2% in pure 
oxygen) and sacrificed through cervical dislocation. The 
brain was quickly removed, and the hippocampal 
formation was homogenized in lysis buffer containing 20 
mM Tris-HCl, pH 7.5, 1% SDS, 1 mM Na3VO4, 1 mM 
PMSF, 5% β-mercaptoethanol, and protease inhibitors 
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(Sigma-Aldrich). Protein concentration was determined 
using the Bradford method [34]. Equivalent amounts (30 
µg) of protein were subjected to electrophoresis on a 4–
12% Mini- PROTEAN® TGX™ Gel (Bio-Rad) and 
transferred to a Hybond ECL nitrocellulose membrane 
(GE Healthcare Bio-Science). The following primary 
antibodies were used: rabbit polyclonal anti-GAPDH 
(1:5000, Sigma-Aldrich), rabbit polyclonal anti-XRCC5 
(1:5000; Elabscience) and rabbit polyclonal anti-
phospho-H2AX-Ser139 (1:1000; Abcam). An HRP-
conjugated goat anti-rabbit IgG secondary antibody 
(1:5000; Jackson Immunoresearch) was used. 
Densitometric analysis of digitized images was performed 
using Chemidoc XRS Imaging Systems and Image 




Data from single animals represented the unity of 
analysis. Results are presented as mean ± standard error 
of the mean (± SE). Statistical analysis was performed 
using SPSS (version 23) or GraphPad Prism (version 6). 
All datasets were analyzed using the ROUT method (Q = 
1%) to identify significant outliers and the Shapiro-Wilk 
test for normality. Datasets with normal distribution were 
analyzed for significance using a two-way analysis of 
variance (ANOVA) with genotype and age as factors. Post 
hoc multiple comparisons were carried out using the 
Fisher least significant difference (Fisher’s LSD) test. 
Datasets with nonparametric distribution were analyzed 
using the Kruskal-Wallis test. Post hoc multiple 
comparisons were carried out using Dunn’s multiple 
comparison test. For the learning phase of the MWM test, 
statistical analysis was performed using a repeated 
ANOVA. F-values for individual statistical analyses is 
reported in Supplementary Table 2. A probability level of 




Behavioral phenotypes in middle-aged Cdkl5 -/Y mice 
 
To determine the effect of age on physical parameters in 
Cdkl5 KO mice, the body weight of Cdkl5 +/Y and Cdkl5 
-/Y male mice was monitored longitudinally at 1, 2, 3, 6, 
and 12 months of age (Table 1). No significant weight 
differences were observed between genotypes in male 
Cdkl5 KO mice, but a similar increment in the body 
weight/age trend was observed (Table 1).  
Adult Cdkl5 KO mice exhibit numerous behavioral 
deficits, including autistic-like behaviors, defects in motor 
coordination, and memory performance [9, 13, 35]. To 
establish whether these behavioral defects are retained or 
worsen at older development stages, we compared 
autistic-like, cognitive, and motor behaviors in adult (2- 
to 4-month‐old) versus middle-aged (12- to 14-month‐
old) Cdkl5 -/Y mice.  
To evaluate the autistic-like phenotype, we analyzed 
exploration and interest in the environment using the 
marble burying test. Both adult and middle-aged Cdkl5 -
/Y mice buried a significantly lower number of marbles 
compared to their wild-type counterparts of the same age 
(Fig. 1A). Interestingly, while no age-dependent 
behavioral decline was observed in Cdkl5 +/Y mice, 
middle-aged Cdkl5 -/Y mice buried fewer marbles 
compared to younger Cdkl5 -/Y mice (Fig. 1A), 
suggesting an age-dependent worsening of the autistic-
like behavior. 
Learning and memory were tested using a classic 
fear conditioning paradigm in which an innate freezing 
response was used as a readout for the ability of mice to 
learn and remember a context or an acoustic cue that is 
associated with an electric shock. We found a reduced 
(albeit not significant in younger animals) percentage of 
freezing time in Cdkl5 -/Y mice during the re-presentation 
of both the context and the acoustic cue compared to their 
wild-type counterparts of the same age (Fig. 1B). 
Interestingly, middle-aged Cdkl5 -/Y mice showed, in 
both paradigms, a reduced percentage of freezing time in 
comparison with younger Cdkl5 -/Y mice (Fig. 1B), 
suggesting an age-dependent worsening of memory 
performance.  
Hippocampus-dependent learning and memory were 
evaluated using the Morris Water Maze (MWM). Mice 
were tested for their ability to find a hidden platform for 
5 days (learning phase) and were subjected to the probe 
test on day 6 (memory phase). Both young adult and 
middle-aged Cdkl5 -/Y mice exhibit severe deficits in 
learning and memory (Supplementary Fig. 1A-C), but do 
not show differences in swimming speed (Supplementary 
Fig. 1D). After the hidden platform test, mice were tested 
with a visible platform MWM task. The aim of the visible 
platform test was to evaluate visual and motivational 
impairments in Cdkl5 KO mice. While all Cdkl5 +/Y mice 
of both ages quickly swam to the visible platform, 5.9% 
of young adult Cdkl5 -/Y mice (1 out of a total of 17 mice) 
and, interestingly, 38% of middle-aged Cdkl5 -/Y mice (8 
out of a total of 21 mice) did not swim to the visible 
platform during the 60 sec of the trial. Since Cdkl5 KO 
mice are characterized by impaired visual responses, we 
evaluated cortical visual responses using non-invasive 
transcranial intrinsic optical signal (IOS) imaging to 
compare visual impairment in young adult and middle-
aged Cdkl5 -/Y mice. Young adult and middle-aged Cdkl5 
-/Y mice showed a similar defect in visual responses 
compared with their wild-type counterparts of the same 
age (Supplementary Fig. 2), suggesting that the failure to 
reach the visual platform of 38% shown by middle-aged 
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Cdkl5 -/Y mice was not due to a worsening of visual 
responses, but might be attributed to less motivation 
regarding their environment. 
We assessed the motor coordination of Cdkl5 KO 
mice on an accelerating rotarod by evaluating the 
frequency of passive rotations (number of passive 
rotations/sec). Passive rotations, rotations in which the 
mouse does not perform any coordinated movements and 
is passively transported by the rotating apparatus, are a 
sign of motor coordination impairment [35]. Rotarod 
performance notably differed between Cdkl5 +/Y and 
Cdkl5 -/Y mice, with Cdkl5 -/Y mice showing 
significantly more passive rotations (Fig. 1C). In 
particular, middle-aged Cdkl5 -/Y mice showed a very 
high frequency of passive rotations, that was significantly 
greater than that of adult Cdkl5 -/Y mice (Fig. 1C), 
indicating an age-dependent worsening of motor 
coordination. 
Finally, in order to examine the effect of age on 
motor stereotypies, mice were tested for hind-limb 
clasping. While Cdkl5 +/Y mice at both ages exhibited 
very little hind-limb clasping, adult Cdkl5 -/Y mice spent 
about 1/4 of the test session (120 sec) in the clasping 
position (Fig. 1D). Again, middle-aged Cdkl5 -/Y mice 
showed an age-dependent worsening of behavior with a 





Figure 2. Sleep apnea and hypnic occurrence rate in Cdkl5 KO mice. (A) Apnea occurrence rate during non-rapid-eye-movement 
sleep (NREM) sleep period in young adult Cdkl5 -/Y (n = 8) and Cdkl5 +/Y (n = 9) mice, and middle-aged Cdkl5 -/Y (n = 14) and 
Cdkl5 +/Y (n = 14) mice. (B) Percentage of time spent in wakefulness, in NREM, and in rapid-eye-movement sleep (REM) during 
whole-body-plethysmography recordings in the same animals as in A. Values represent mean ± SEM. *p< 0.05, **p< 0.01, ***p< 
0.001 (Fisher’s LSD test after two-way ANOVA). 
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Figure 3. Impaired dendritic morphology in Cdkl5 KO mice. (A) Example of a Golgi-stained brain slice. The dotted 
boxes highlight the brain regions of the hippocampal formation (granular layer (DG) and hippocampal CA1 region 
(CA1)) and the visual cortex (V1) where dendritic length and spine density and maturation were evaluated. Scale bar = 
500 μm. (B-C) Mean total dendritic length (B) and mean number of dendritic segments (C) of Golgi-stained granule 
cells of the dentate gyrus (DG) in adult Cdkl5 -/Y (n = 3) and Cdkl5 +/Y (n = 3) mice, and middle-aged Cdkl5 -/Y (n = 
3) and Cdkl5 +/Y (n = 3) mice. (D) Examples of the reconstructed dendritic tree of Golgi-stained mature granule neurons 
of one animal from each experimental group. Scale bar = 100 μm. (E-F) Mean total dendritic length (E) and mean 
number of basal dendritic segments (F) of Golgi-stained pyramidal neurons of the primary visual cortex (V1, layer 
II/III) in adult Cdkl5 -/Y (n = 4) and Cdkl5 +/Y (n = 4) mice, and middle-aged Cdkl5 -/Y (n = 4) and Cdkl5 +/Y (n = 4) 
mice. (G-H) Dendritic spine density (number of spines per 10 μm) on apical dendrites of pyramidal neurons of the CA1 
layer of the hippocampus (G) and pyramidal neurons of V1 (layer II/III; H) from adult Cdkl5 -/Y (n = 4 or 5, 
respectively) and Cdkl5 +/Y (n = 4) mice, and middle-aged Cdkl5 -/Y (n = 4) and Cdkl5 +/Y (n = 4) mice. Values are 
represented as means ± SE. *p< 0.05, **p< 0.01, ***p< 0.001 (Fisher’s LSD after two-way ANOVA). 
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Respiratory and hypnic phenotypes in middle-aged 
Cdkl5 -/Y mice 
 
An abnormal breathing pattern, with a higher occurrence 
rate of sleep apneas, has been described in adult 4- to 6-
month‐old Cdkl5 KO mice [30, 35], while at this age no 
changes in sleep pattern were observed between 
genotypes [30]. To determine whether Cdkl5 -/Y 
breathing irregularities worsen with age and whether 
Cdkl5 +/Y and Cdkl5 -/Y mice show age-dependent sleep 
disturbances, we compared respiratory and hypnic 
phenotypes in young adult (2‐month‐old) versus middle-
aged (12- to 14-month‐old) mice, using non-invasive 
whole-body plethysmography (WBP). We found that the 
occurrence rate of sleep apneas of 2-month-old Cdkl5 -/Y 
and Cdkl5 +/Y mice did not differ, while middle-aged 
Cdkl5 -/Y mice had more frequent apneas during non‐
rapid eye movement (NREM) sleep compared to Cdkl5 
+/Y mice (Fig. 2A). In further analyses, as a function of 
apnea type, middle-aged Cdkl5 -/Y differed significantly 
from middle-aged Cdkl5 +/Y in terms of higher 
occurrence rate of both post-sigh apneas (Cdkl5 +/Y 
4.312±3.588; Cdkl5 -/Y 7.561±4.204 p = 0.0247) and the 
apneas that did not follow a sigh (Cdkl5 +/Y 1.121±0.439; 
Cdkl5 -/Y 2.544±1.894 p = 0.0122) during NREM sleep.  
The sleep pattern of Cdkl5 -/Y mice did not differ 
significantly from that of Cdkl5 +/Y mice either in terms 
of percentage of wakefulness or of NREM sleep (Fig. 2B). 
In contrast, middle-aged Cdkl5 -/Y mice spent a higher 
percentage of time in REM sleep compared to Cdkl5 +/Y 
mice of the same age (Fig. 2B), suggesting an age-
dependent sleep perturbation in the absence of CDKL5. 
No significant differences in respiratory or hypnic 
variables were found between young (2‐month‐old) Cdkl5 
+/Y and Cdkl5 -/Y mice (Fig. 2B). 
 
Dendritic abnormalities in middle-aged Cdkl5 -/Y 
mice 
 
In order to establish whether the decline in 
behavioral performance in middle-aged Cdkl5 -/Y mice is 
due to a deterioration of the dendritic pathology that 
characterizes Cdkl5 KO mice, we analyzed dendritic 
architecture and spine density/maturation in the 
hippocampus and cortex of Cdkl5 -/Y mice. 
In Golgi-stained brain sections we examined the 
dendritic tree of granule cells of the dentate gyrus (DG) 
and pyramidal neurons of the primary visual cortex (V1) 
(Fig. 3A-F). Granule neurons of young adult and middle-
aged Cdkl5 -/Y mice displayed a similar lower dendritic 
length (Fig. 3B, D) in comparison with Cdkl5 +/Y 
counterparts of the same age, due to a reduction in the 
number of branches (Fig. 3C, D). Similarly to granule 
neurons, pyramidal neurons of layer II/III of V1 exhibited 
dendritic hypotrophy, and a reduction in dendritic length 
(Fig. 3E) as well as in the number of branches (Fig. 3F). 
Evaluation of dendritic spine density showed that 
both the pyramidal neurons of the hippocampus (CA1 
field, Supplementary Fig. 3A) and cortex (V1) had a 
similar lower spine density in young adult and middle-
aged Cdkl5 -/Y mice in comparison with Cdkl5 +/Y 
counterparts of the same age (Fig. 3G, H). Although, with 
age, regional differences in spine maturation are observed 
(Supplementary Fig. 3B), separate counts of different 
classes of dendritic spines revealed that the hippocampal 
and cortical pyramidal neurons of young adult and 
middle-aged Cdkl5 -/Y mice had a higher percentage of 
immature spines and a reduced percentage of mature 
spines compared to age-matched Cdkl5 +/Y mice 
(Supplementary Fig. 3B). A similar reduction in mature 
spine density in the cerebral cortex (V1 and S1) of Cdkl5 
-/Y mice at both ages was confirmed by the analysis of 
Homer1bc puncta density, a reliable postsynaptic marker 
of fully developed dendritic spines [36] (Supplementary 
Fig. 4). Finally, when we studied putative excitatory 
synaptic contacts, identified through the simultaneous 
labelling of both VGluT1 (excitatory presynaptic marker) 
and Homer1bc, we found that VGluT1+ terminals 
juxtaposed to Homer1bc+ puncta were significantly lower 
in the cerebral cortices of Cdkl5 -/Y mice at both ages 
compared to their Cdkl5 +/Y counterparts (Fig. 4).  
 
c-Fos expression in middle-aged Cdkl5 -/Y mice 
 
We have previously shown that in 6- to 8-week-old Cdkl5 
-/Y mice the reduction in c-Fos expression detected by 
immunohistochemistry is a robust cortical 
endophenotype, most likely indicating less neuronal 
activation [17, 18]. To assess whether defects in the 
expression levels of the immediate early gene c-Fos 
parallel the decline in behavioral performance in middle-
aged Cdkl5 -/Y mice, we evaluated the number of c-Fos 
positive neurons in the CA1 field of the hippocampus as 
well as in the S1 and V1 cortices of both 2- and 12-month-
old Cdkl5 KO mice. As shown in Figure 5 the number of 
c-Fos immunoreactive cells is clearly reduced in these 
three brain areas (Fig. 5 A, C and E) of Cdkl5 -/Y mice at 
both ages. In agreement with this, the quantitative 
analyses revealed a statistically significant reduction in 
the density of c-Fos positive neurons between genotypes 
but no age differences (Fig. 5B, D and F), indicating that 
a reduction in c-Fos expression is not dependent on the 
age of Cdkl5 -/Y mice.  
 
Neuronal survival in middle-aged Cdkl5 Y/- mice 
 
In order to evaluate whether a loss of Cdkl5 affects 
neuronal survival rate in elderly mice, we first evaluated 
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cell density in the CA1 layer of the hippocampus (Fig. 6 
A-C). We found that middle-aged Cdkl5 -/Y mice showed 
a reduced cell number and an increase in the number of 
pyknotic nuclei in the CA1 layer in comparison with age-
matched Cdkl5 +/Y mice (Fig. 6A, B). To confirm the 
reduced neuronal survival rate, we counted the number of 
NeuN-positive pyramidal neurons in the CA1 layer. We 
found a reduction in NeuN-positive neurons in both young 
adult and middle-aged Cdkl5 -/Y mice compared to age-
matched Cdkl5 +/Y mice (Fig. 6C). Importantly, although 
a reduction in NeuN-positive neurons was present in 
middle-aged Cdkl5 +/Y mice, the reduction was 




Figure 4. Cdkl5 KO mice exhibit a decrease in the number of excitatory synaptic contacts. (A, C) Representative confocal 
micrographs of the neuropil in layer II-III of both S1 (A) and V1 (C) cortices showing immunofluorescence staining for VGluT1 
(green) and Homer1bc (red) in young adult and middleaged Cdkl5 +/Y and Cdkl5 -/Y mice. Scale bar 5 μm. Arrows point to 
examples of VGluT1-Homer1bc coappositions. Arrowheads point to examples of solitary VGluT1+ terminals. (B, D) Quantitative 
analysis of the percentage of VGluT1+ terminals juxtaposed to Homer1bc+ in cerebral cortex from young adult Cdkl5 -/Y (n = 4) 
and Cdkl5 +/Y (n = 5) mice, and middle-aged Cdkl5 -/Y (n = 3) and Cdkl5 +/Y (n = 4) mice. Values are represented as means ± 
SE. **p<0.01, ***p<0.001 (Fisher’s LSD test after two-way ANOVA 
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Figure 5. Cdkl5 KO mice exhibit a reduction of the number of c-fos. (A, C, E) Representative examples of c-Fos 
staining obtained from the pyramidal cell layer of the hippocampal CA1 (A), and from the primary somatosensory S1 
(C) and primary visual cortices V1 (E) of young adult and middle-aged Cdkl5 +/Y and Cdkl5 -/Y mice. Scale bar = 
50μm. (B) Quantification of the density of c-Fos immunoreactive cells in the CA1 layer from young adult Cdkl5 +/Y (n 
= 6) and Cdkl5 -/Y (n = 7) mice, and middle-aged Cdkl5 +/Y (n = 3) and Cdkl5 -/Y (n = 4) mice. (D) Quantitative 
analysis of the density of c-Fos positive cells in the S1 cortex of young adult Cdkl5 +/Y (n = 8) and Cdkl5 -/Y (n = 10) 
mice, and middle-aged Cdkl5 +/Y (n = 4) and Cdkl5 - /Y (n = 3) mice. (F) Quantification of c-Fos positive cells in the 
V1 cortex of young adult Cdkl5 +/Y (n = 5) and Cdkl5 -/Y (n = 5) mice, and middle-aged Cdkl5 +/Y (n = 3) and Cdkl5 
-/Y (n = 3) mice. Values are represented as means ± SE. *p<0.05, **p<0.01, ***p<0.001 (Fisher’s LSD test after two-
way ANOVA). 
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Figure 6. Reduced neuronal survival in Cdkl5 KO mice. (A) Quantification of Hoechst-positive cells in CA1 of hippocampal 
sections from young adult Cdkl5 +/Y (n = 4) and Cdkl5 -/Y (n = 4) mice, and middleaged Cdkl5 +/Y (n = 4) and Cdkl5 -/Y (n = 
4) mice. (B) Quantification of pyknotic cells in the CA1 layer of the hippocampus from mice as in B. (C) Quantification of 
NeuN-positive cells in CA1 of hippocampal sections from young adult Cdkl5 +/Y (n = 4) and Cdkl5 -/Y (n = 4) mice, and 
middle-aged Cdkl5 +/Y (n = 5) and Cdkl5 -/Y (n = 4) mice. (D) Representative fluorescence images of cell layers in the 
hippocampal CA1 region from young adult and middle-aged Cdkl5 +/Y and Cdkl5 -/Y mice. Arrows indicate pyknotic nuclei. 
Scale bar = 100 μm. E) Representative fluorescence images of sections immunopositive for NeuN (red) and counterstained with 
Hoechst (blue) in the hippocampal CA1 region of one animal from each group. Scale bar = 100 μm. Values are represented as 
means ± SE. *p<0.05, **p<0.01, ***p<0.001 (Fisher’s LSD test after two-way ANOVA). 
Apoptotic cell death was evaluated by counting the 
number of cleaved caspase-3-positive cells (Fig. 7A-C). 
An increase in cell death was already present in young 
adult Cdkl5 -/Y mice, but it was significantly higher in 
middle-aged Cdkl5 -/Y mice (Fig. 7A, C). Similarly, we 
found increased apoptosis in the S1 cortex of middle-aged 
Cdkl5 -/Y mice (Fig. 7B, C). 
Since reactive gliosis is a hallmark of 
neurodegeneration [37], we evaluated the number of 
GFAP-positive cells in the molecular layer of the 
hippocampal DG of adult and middle-aged Cdkl5 KO 
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mice. We observed a higher number of GFAP-positive 
cells in middle-aged Cdkl5 -/Y mice in comparison with 
Cdkl5 +/Y mice (Supplementary Fig. 5A, B), an increase 
that was not present in young adult Cdkl5 -/Y mice 
(Supplementary Fig. 5A, B). In contrast, an increase in the 
number of S100-positive astrocytes was present in the 
cortex of both young adult and middle-aged Cdkl5 -/Y 
mice compared to age-matched Cdkl5 +/Y mice 
(Supplementary Fig. 5C, D). The increase was 
significantly higher in middle-aged Cdkl5 -/Y mice 
compared to young adult Cdkl5 -/Y mice (Supplementary 




Figure 7. Increased neuronal cell death in Cdkl5 KO mice. (A-B) Quantification of cells positive for cleaved 
caspase-3 in the CA1 layer of the hippocampus (A) and in layer II/III of the somatosensory cortex (S1, B) from young 
adult Cdkl5 +/Y (n = 4) and Cdkl5 -/Y (n = 4) mice, and middle-aged Cdkl5 +/Y (n = 4) and Cdkl5 -/Y (n = 4) mice. 
(C) Representative images, one from each group, of cells, in the hippocampal CA1 region (upper panel) and in layer 
II/III of the somatosensory cortex (S1 , lower panel), immunopositive for cleaved caspase-3 (red) and stained with 
Hoechst (blue). Scale bar = 50 μm. (D) Quantification of the total number of TH-positive neurons in the substantia 
nigra (SN) and ventral tegmental area (VTA) from young adult Cdkl5 +/Y (n = 5) and Cdkl5 -/Y (n = 4) mice, and 
middle-aged Cdkl5 +/Y (n = 4) and Cdkl5 - /Y (n = 5) mice. (E) Representative images of tyrosine hydroxylase (TH) 
immunofluorescence staining in the VTA and SN of middle-aged Cdkl5 +/Y and Cdkl5 -/Y mice. Scale bar = 100 μm. 
The dotted boxes indicate the VTA region shown at a higher magnification in the right panel. Scale bar = 40 μm. 
Values are represented as means ± SE. *p<0.05, **p<0.01, ***p<0.001 (Fisher’s LSD test after two-way ANOVA). 
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Figure 8. Senescence-associated-β-galactosidase (SA-β-gal) activity in Cdkl5 KO mice. (A) Representative 
image at low magnification of a hippocampus of a middle-aged Cdkl5 -/Y mouse. Scale bar = 500 μm. The dotted 
boxes indicate the regions used for quantification in (D-F). (B-C) Higher magnification shows representative images 
of SA-β-gal staining in the hippocampal CA3 (B) and CA1 (C) region from adult and middle-aged Cdkl5 +/Y and 
Cdkl5 -/Y mice. Scale bar = 50 μm. (D-F) Quantification of SA-β-gal intensity in CA3 (D) and CA1 (E) hippocampal 
layers, and in layer II/III of the S1 cortex (F) from young adult Cdkl5 +/Y (n = 3) and Cdkl5 -/Y (n = 4) mice, and 
middle-aged Cdkl5 +/Y (n = 4) and Cdkl5 -/Y (n = 3) mice. Values are represented as means ± SE. *p< 0.05, **p< 
0.01, ***p< 0.001 (Fisher’s LSD test after two-way ANOVA). 
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Figure 9. Increased DNA damage in the hippocampus of Cdkl5 KO mice. (A-B) Representative fluorescent 
images of the CA3 (A) and CA1 (B) hippocampal regions of adult and middle-aged Cdkl5 +/Y and Cdkl5 -/Y 
mice, immunostained for γH2AX and counterstained with Hoechst. Scale bar = 500 μm  (C) Quantification of 
γH2AX nuclear signal intensity in the CA3 and CA1 pyramidal layer of young adult Cdkl5 +/Y (n = 3) and 
Cdkl5 -/Y (n = 3) mice, and middle-aged Cdkl5 +/Y (n = 4) and Cdkl5 -/Y (n = 3) mice. (D) Western blot 
analysis of γH2AX levels normalized to GAPDH levels in the hippocampus of young adult Cdkl5 +/Y (n = 4) 
and Cdkl5 -/Y (n = 5) mice, and middle-aged Cdkl5 +/Y (n = 3) and Cdkl5 -/Y (n = 3) mice. (E) Western blot 
analysis of XRCC5 levels normalized to GAPDH levels in the hippocampus of young adult Cdkl5 +/Y (n = 4) 
and Cdkl5 -/Y (n = 5) mice, and middle-aged Cdkl5 +/Y (n = 4) and Cdkl5 -/Y (n = 3) mice. (F) Immunoblot 
images of γH2AX, XRCC5, and GAPDH levels in protein extracts from one animal of each experimental 
group. Data in Western blot analysis are expressed as a percentage of the values compared to young adult 
Cdkl5 +/Y mice. Values are represented as means ± SE. *p< 0.05 and **p< 0.01, ***p<0.001 (Fisher’s LSD 
test after two-way ANOVA). 
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To determine whether impaired neuronal survival 
could be extended to other brain regions and other 
neuronal subtypes, we evaluated the total number of 
dopaminergic neurons in the substantia nigra (SN) and 
ventral tegmental area (VTA) of the midbrain (Fig. 7D, 
E). We found that the number of tyrosine hydroxylase 
(TH)-positive cells was significantly lower in middle-
aged Cdkl5 -/Y mice compared to Cdkl5 +/Y mice (Fig. 
7D, E), while there was no difference in the number of 
TH-positive cells between young adult Cdkl5 -/Y and 
Cdkl5 +/Y mice (Fig. 7D, E). 
 
Neuronal senescence in middle-aged Cdkl5 -/Y mice 
 
Cells with features of senescence have been detected in 
the context of brain aging and neurodegenerative disease 
[38]. To evaluate senescent cells in Cdkl5 KO mice we 
used a common marker: intracellular level of β-
galactosidase (SA-β-GAL) activity. Interestingly, we 
observed an intense staining of the whole hippocampus 
(Fig. 8A), and in particular the CA3 layer, in middle-aged 
Cdkl5 -/Y mice (Fig. 8B, D), but a low level of staining in 
their wild-type (Cdkl5 +/Y) counterparts and in young 
adult Cdkl5 -/Y and +/Y mice (Fig. 8B, D). Similarly, 
middle-aged Cdkl5 -/Y mice showed a higher level of SA-
β-GAL staining in the CA1 layer of the hippocampus and 
in S1, compared to Cdkl5 +/Y mice of the same age (Fig. 
8C, E, F). 
 
DNA damage in middle-aged Cdkl5 -/Y mice 
 
Defective DNA repair with accumulation of unrepaired 
DNA is an underlying cause of brain aging [39]. 
Interestingly, a recent finding suggests that CDKL5 plays 
a role in the regulation of the DNA repair process [23]. To 
determine whether reduced neuronal survival and 
increased senescence in Cdkl5 -/Y mice is paralleled by 
an increased DNA damage response, we analyzed the 
presence of DNA double-strand breaks in hippocampal 
neurons of Cdkl5 KO mice by assaying for the levels of 
phospho-histone H2AX (γH2AX). We found that both 
young adult and middle-aged Cdkl5 -/Y mice showed a 
higher level of γH2AX immunostaining in comparison 
with Cdkl5 +/Y mice of the same age (Fig. 9A-C). 
Moreover, although γH2AX levels increased with age in 
both Cdkl5 +/Y and Cdkl5 -/Y mice (Fig. 9A-C), middle-
aged Cdkl5 -/Y showed the highest levels of γH2AX 
immunostaining (Fig. 9A-C) in both layers that were 
analyzed: CA3 and CA1. Similarly, the expression levels 
of γH2AX and of the double-strand break (DSB)-repair 
protein, XRCC5, analyzed using Western blot analyses, 
were higher in hippocampal extracts of middle-aged 
Cdkl5 -/Y mice compared to young Cdkl5 -/Y mice and to 
Cdkl5 +/Y mice of the same age (Fig. 9D-F), suggesting 
increased DNA damage in the absence of Cdkl5 as a 




Although the clinical aspects associated with CDKL5 
mutations are well described in children, adults with CDD 
are still under-characterized. An age-related analysis of 
the phenotype in CDD is an important research priority 
for a better understanding of the time‐related progression 
of the multiple symptoms that may be involved in this 
pathology, thus allowing them to be targeted more 
effectively using appropriate treatment strategies. 
Although very little is known regarding the life 
expectancy of CDD patients, there are currently no 
reported cases of CDD patients older than middle-aged 
(40-45 years; [7]), suggesting a shortened lifespan. 
Therefore, based on the reported CDD human cases (most 
of them are under 18 years of age; [7]), we decided to 
analyze the phenotype of young/adult Cdkl5 KO mice (2-
4 months in the mouse corresponding to 6-15 years in 
humans; [40]) in comparison with middle-aged Cdkl5 KO 
mice (12-14 months in the mouse corresponding to 40-45 
years in humans; [40]). In this study, we report an age-
dependent decline in motor, cognitive, and social 
behaviors in Cdkl5 KO mice. We found a decreased 
neuronal survival in middle-aged Cdkl5 KO mice that was 
paralleled by an increase in neuronal senescence and 
DNA repair protein levels. Our findings suggest that the 
absence of CDKL5 accelerates neuronal senescence by 
triggering irreparable DNA damage, and thereby provide 
evidence that CDKL5 may play a fundamental role in 
neuronal survival during brain aging.  
 
Worsening of the behavioral phenotype with age in 
Cdkl5 KO mice 
 
Autistic-like (ASD-like) features, including disinterest in 
the surrounding environment, intellectual disability, and 
motor dysfunction are prominent features of CDKL5 
deficiency and have been commonly described in Cdkl5 
KO mouse models. Our finding that middle-aged Cdkl5 -
/Y mice showed a further decreased interest in the 
environment (reduced marble burying and failure to reach 
the visible platform in the Morris water maze paradigm) 
in comparison to young adult Cdkl5 -/Y mice, indicates an 
age-dependent worsening of ASD-like features in the 
absence of CDKL5.  
Importantly, cognitive abilities, such as memory 
acquisition, were characterized by a further deterioration 
in middle-aged Cdkl5 -/Y mice. Likewise, middle-aged 
Cdkl5 -/Y mice showed an increased frequency of 
uncoordinated rotations on the rotating rod, and a longer 
clasping time, indicating a worsening in motor 
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coordination and stereotypies. Since we did not find a 
similar behavioral deterioration in middle-aged wild-type 
mice, the behavioral worsening in older Cdkl5 -/Y mice 
indicates a CDKL5-dependent deterioration of the 
neurological phenotype. 
Our findings that complex behaviors such as sleep, 
and breathing are age-dependent in the Cdkl5 KO mouse 
support our hypothesis of a worsening of the behavioral 
phenotype with age in CDD. We previously found that 
there is a difference in breathing during sleep between 
Cdkl5 KO and wild‐type adult mice (4 to 6 months-old). 
In particular, we demonstrated that Cdkl5 -/Y adult mice 
showed more frequent sleep apneas compared to Cdkl5 
+/Y [30] mice, and that, at least in adult (4- to 6- month-
old) mice, sleep apneas are a core feature of CDKL5 
disorder and a respiratory biomarker of CDKL5 
deficiency. In the present study, we showed that young (2-
month-old) mice have a completely normal sleep and 
breathing phenotype; on the contrary, we found different 
changes in sleep and breathing phenotype in Cdkl5 -/Y at 
12 months of age, with a significant increase in NREM 
sleep apneas compared to Cdkl5 -/Y. These data confirm 
the results that we previously found in 4-6 month-old 
Cdkl5 -/Y mice [30]. Furthermore, the present study 
demonstrated that at the age of 12 months Cdkl5 -/Y mice 
also show a significant increase in post-sigh apneas, 
which had not significantly increased at the age of 4 to 6 
months. This suggests the presence of a progressive age-
dependent derangement of the respiratory phenotype in 
Cdkl5 -/Y mice. 
Moreover, REM sleep time in middle-aged Cdkl5 -
/Y mice is increased compared to that of control mice. 
This is interesting, because REM sleep disturbances and 
increased REM sleep duration have been considered as 
biological markers of depression [41], and REM sleep 
represents an element of the response to chronic stress 
[42]. Thus, this specific modification of the hypnic 
phenotype that appears in 12-month-old Cdkl5 -/Y mice 
may represent an index of age-dependent behavioral 
dysfunction.  
 
Synaptic and dendritic pathology does not worsen with 
age in Cdkl5 KO mice 
 
Changes in neuronal morphology have consistently been 
reported in several Cdkl5 KO mouse models [9, 10]. 
Neuronal tracing of Golgi-stained, or DCX-stained cells 
in juvenile and adult Cdkl5 KO mice showed a reduction 
in dendritic length in cortical and hippocampal pyramidal 
neurons, as well as in hippocampal granule cells [9, 13-
15]. Furthermore, Cdkl5 KO mice show changes in the 
maturation and stability, as well as in the density, of 
dendritic spines in several brain structures 
(somatosensory, visual and perirhinal cortex, 
hippocampus, and thalamus) [13, 15-17, 43, 44]. 
Dendritic pathology is a possible substrate for mental 
retardation in different conditions. In CDD mouse 
models, the pathogenesis of dendritic abnormalities is 
distinctive and appears to correlate with the cognitive 
profile [9, 13-15]. Our finding that defects in neuronal 
maturation as well as in synapse development and 
configuration do not worsen with age, indicates that the 
behavioral decline in middle-aged Cdkl5 -/Y mice is not 
caused by a worsening of the dendritic pathology. 
 
Increased neuronal cell death in middle-aged Cdkl5 KO 
mice  
 
The role of CDKL5 in neuronal survival has recently been 
described [22]. In particular, Cdkl5 KO neurons have been 
demonstrated to be more prone to cell death since they are 
more vulnerable to neurotoxic/excitotoxic stimuli [22]. 
During aging, neuronal cells are subjected to increased 
oxidative stress, perturbed energy homeostasis and 
mutations in nucleic acids. We assume that these 
alterations make CDKL5 KO neurons more vulnerable 
during aging, as suggested by the increased cell death 
found in the brains of middle-aged Cdkl5 -/Y mice. Death 
of neurons adversely affects both the pre- and post-
synaptic neurons with which they communicate. 
Therefore, a small neuronal degeneration, such as that 
observed in older Cdkl5 KO mice, may cause a serious 
brain dysfunction for a domino-like effect. As a 
neurochemical marker that is putatively associated with 
the increased neurodegeneration, we found an astrocytic 
hyperactivity in the brains of older Cdkl5 KO mice. Since 
the astrocytic marker S100 is expressed by a subtype of 
mature astrocytes that ensheath blood vessels, and by 
NG2-expressing cells, which are precursors to 
oligodendrocytes [45-47], we cannot exclude the 
possibility that other alterations, regarding blood-brain 
barrier permeability or the axonal myelination, may occur 
in elderly Cdkl5 KO mice. 
Unlike neurodegenerative disorders, most of which 
are characterized by the degeneration of a specific 
neuronal population, the absence of CDKL5 did not reveal 
a selective neuronal vulnerability. Our findings show that 
neuronal death occurs in different brain regions 
(hippocampus, cortex, and basal ganglia) and affects 
different neuronal populations in older Cdkl5 KO mice, 
supporting the general decline in behavior, including the 
impairment of motor and cognitive functions. While the 
decline in memory performance in middle-aged Cdkl5 KO 
mice correlates well with decreased hippocampal neuron 
survival, we can speculate that motor impairment may 
depend on the loss of TH-positive neurons.  
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Increased neuronal senescence and damaged DNA 
response with age in Cdkl5 KO mice  
 
As an indicator of senescence (SA-β-GAL) is more active 
in a variety of cell types of the Cdkl5 KO mouse brain 
with age, it is tempting to speculate that senescent cells, 
which are more susceptible to death, contribute to 
negatively influence behavior in older Cdkl5 KO mice. 
Senescence is associated with increased amounts of 
damaged DNA in neurons which may result from 
impaired DNA repair systems [39]. Genetic diseases 
caused by defects in DNA damage repair (DDR) are 
associated with premature aging syndromes with 
neurodegenerative phenotypes; this is consistent with the 
impairment of these systems playing a role in normal 
aging of the nervous system. Accordingly, we found that 
loss of Cdkl5 promotes both premature cellular 
senescence and endogenous DDR signaling by increasing 
γH2AX and XRCC5 levels in the brain of older Cdkl5 KO 
mice, suggesting that accumulation of nuclear DNA 
damage stimulates the activity of proteins that hold key 
functional roles in DNA repair and, subsequently, triggers 
the initiation of cellular senescence. 
Since several lines of evidence indicate that the 
activity of kinases, including MAP kinases, decreases 
during aging [48-50], it can be speculated that an age-
dependent decline of CDKL5 activity might be implicated 
in the physiological neuronal senescence. Although, to 
date, very little is known regarding the post-translational 
modifications of CDKL5 or its molecular targets, the 
presence of a TXT activation motif of MAP kinases in its 
sequence and of a putative signal peptidase I serine active 
site, suggests that CDKL5 activity might be affected by 
post-translational modifications, according to neuronal 
maturation or age. 
In conclusion, our study indicates that the 
upregulated neuronal vulnerability due to reduced DNA 
repair and increased cellular senescence might play a role 
in neuronal dysfunction and impaired behavior in older 
Cdkl5 KO mice. Based on our results, a worsening of the 
clinical symptoms in adult and elderly CDD patients 
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